Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Research & Development: 2009-2024

Historic Research & Development for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $19,000.

  • Rockwell Medical's Research & Development fell 99.40% to $1,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $681,000, marking a year-over-year decrease of 38.48%. This contributed to the annual value of $19,000 for FY2024, which is 98.28% down from last year.
  • As of FY2024, Rockwell Medical's Research & Development stood at $19,000, which was down 98.28% from $1.1 million recorded in FY2023.
  • Rockwell Medical's 5-year Research & Development high stood at $7.1 million for FY2020, and its period low was $19,000 during FY2024.
  • Moreover, its 3-year median value for Research & Development was $1.1 million (2023), whereas its average is $1.4 million.
  • In the last 5 years, Rockwell Medical's Research & Development climbed by 2.90% in 2020 and then plummeted by 98.28% in 2024.
  • Rockwell Medical's Research & Development (Yearly) stood at $7.1 million in 2020, then decreased by 3.73% to $6.8 million in 2021, then tumbled by 54.37% to $3.1 million in 2022, then tumbled by 64.51% to $1.1 million in 2023, then slumped by 98.28% to $19,000 in 2024.